Hepatitis B core total antibodies
- Description
- Qualitative chemiluminescent immunoassay (CLIA) for the detection of total antibodies to Hepatitis B core in serum. A positive core antibody indicates past or current infection with Hepatitis B. Positive samples will undergo further testing for other Hepatitis B markers to determine whether there is chronic ongoing infection. Patients with a positive core antibody in isolation are still at risk of re-activating hepatitis B if significantly immunosuppressed. May be temporarily positive in patients who have recently received blood products, "false positive". This assay is available as a screening or follow-up test Mon to Sun, with a turnaround time of 3 working days. This test is not UKAS accredited
- Clinical details
- Hepatitis B infection can lead to significant liver disease which can be prevented either by pre-exposure vaccination or with medical treatment in chronic infection.
- Related condition
- Reference range
Not Applicable
- Units
- Qualitative test - Detected/Not detected
- Synonyms
- HepB, HBV, Core total
- Testing site
- Synnovis : Infection Sciences : Blackfriars Hub
- Laboratory
- Virology
- Sample type and volume required
- 2.5 - 5ml Yellow Top Serum Separation Tube (SST) Clotted Blood (for serum).
- Storage and transport
- Place labelled sample in a sealed sample bag and send to Central Specimen Reception (CSR). To prevent sample haemolysis, please store samples in refrigerator if there is a delay in sending samples to CSR.
- Turnaround time
- 3 working days
- Contacts
- For the most up-to-date contact list and service information, please refer to the User Manual.